Marija Mostarica Stojkovic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Marija Mostarica Stojkovic has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Dusan Popadic
Institute of Microbiology and Immunology, School of Medicine, University of Belgrade, Belgrade, Serbia
3 shared publications Zorica Ramić
2 shared publications- Dragana Janic
Department of Hematology and Oncology, University Children's Hospital, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Serbia
1 shared publication Dušan Popadić
1 shared publication- Emina Milosevic
Institute of Microbiology and Immunology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia
1 shared publication - Goran Rakocevic
Thomas Jefferson University Philadelphia PA United States
1 shared publication
Latest Publications
- Open Access
- 1 July 2014
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Journal of Medical Biochemistry
- Vol. 33 (3) , 265-270
Flow Cytometric Assay of Respiratory Burst Capacity in Peripheral Blood Monocytes of Gaucher Type 1 Patients
Background: There is an apparently increased tendency toward infections in patients with Gaucher disease, possibly due to defective neutrophil function rather than a decreased neutrophil count. Since macrophages are the main cell type affected in Gaucher disease, our aim was to determine the contribution of these cells to the susceptibility of Gaucher patients to infection by studying the respiratory burst capacity of peripheral blood monocytes. Methods: The study was performed in eleven Gaucher type 1 patients and eleven sex and age matched control subjects by measuring peripheral blood monocytes’ respiratory burst capacity using flow cytometry. The respiratory burst capacity was measured as dihydrorhodamine-123 median fluorescence in patients and respective controls. Results: There was no statistical difference in the median fluorescence among the patients and respective controls (p>0.05) after phorbol 12-myristate 13-acetate stimulation. Also, statistical difference was not reached among patients treated with enzyme replacement therapy at the time and those untreated. Conclusions: Flow cytometry might represent a more accurate and more reliable measure of respiratory burst compared to the methods of other researchers. Respiratory burst disturbance in monocytes does not seem to contribute to increased susceptibility to infection in Gaucher patients.
- 1 July 2014
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Journal of Medical Biochemistry
- Vol. 33 (3) , 265-270
Open AccessFlow Cytometric Assay of Respiratory Burst Capacity in Peripheral Blood Monocytes of Gaucher Type 1 Patients
Background: There is an apparently increased tendency toward infections in patients with Gaucher disease, possibly due to defective neutrophil function rather than a decreased neutrophil count. Since macrophages are the main cell type affected in Gaucher disease, our aim was to determine the contribution of these cells to the susceptibility of Gaucher patients to infection by studying the respiratory burst capacity of peripheral blood monocytes. Methods: The study was performed in eleven Gaucher type 1 patients and eleven sex and age matched control subjects by measuring peripheral blood monocytes’ respiratory burst capacity using flow cytometry. The respiratory burst capacity was measured as dihydrorhodamine-123 median fluorescence in patients and respective controls. Results: There was no statistical difference in the median fluorescence among the patients and respective controls (p>0.05) after phorbol 12-myristate 13-acetate stimulation. Also, statistical difference was not reached among patients treated with enzyme replacement therapy at the time and those untreated. Conclusions: Flow cytometry might represent a more accurate and more reliable measure of respiratory burst compared to the methods of other researchers. Respiratory burst disturbance in monocytes does not seem to contribute to increased susceptibility to infection in Gaucher patients.
- 1 May 2009
- Published by Walter de Gruyter GmbH in Serbian Journal of Dermatology and Venereology
- Vol. 1 (2) , 61-67
Antiproliferative effect of docosahexaenoic acid on adult human keratinocytes in vitro / Antiproliferativni efekat dokosaheksanoične kiseline na adultne humane keratinocite in vitro
Numerous clinical studies demonstrate benefits of dietary supplementation with fish oils in autoimmune diseases and other inflammatory diseases such as psoriasis, multiple sclerosis, systemic lupus erythematodes and so on. Docosahexaenoic acid (DHA) is an omega-3 fatty acid which is abundantly found in fish oil. In the present study we investigated effects of DHA on proliferation of human keratinocytes established from skin of seven adult donors, cultivated in growth medium that allows optimal cell proliferation. We found a dose-dependent inhibition of cell proliferation when keratinocytes were incubated with 6.25, 12.5 and 25 -μM of DHA. Inhibition of proliferative capacity considerably varied in keratinocyte cultures derived from different donors, particularly when incubated with the lowest concentration of the assessed substance. Lactate dehydrogenase-release assay excluded necrosis of cultivated keratinocytes as a cause of decreased proliferation. Our results suggest that DHA may potentially be used as a routine adjuvant therapy, with classical therapy of inflammatory hyperproliferative skin diseases.
- 1 May 2009
- Published by Walter de Gruyter GmbH in Serbian Journal of Dermatology and Venereology
- Vol. 1 (2) , 61-67
Antiproliferative effect of docosahexaenoic acid on adult human keratinocytes in vitro / Antiproliferativni efekat dokosaheksanoične kiseline na adultne humane keratinocite in vitro
Numerous clinical studies demonstrate benefits of dietary supplementation with fish oils in autoimmune diseases and other inflammatory diseases such as psoriasis, multiple sclerosis, systemic lupus erythematodes and so on. Docosahexaenoic acid (DHA) is an omega-3 fatty acid which is abundantly found in fish oil. In the present study we investigated effects of DHA on proliferation of human keratinocytes established from skin of seven adult donors, cultivated in growth medium that allows optimal cell proliferation. We found a dose-dependent inhibition of cell proliferation when keratinocytes were incubated with 6.25, 12.5 and 25 -μM of DHA. Inhibition of proliferative capacity considerably varied in keratinocyte cultures derived from different donors, particularly when incubated with the lowest concentration of the assessed substance. Lactate dehydrogenase-release assay excluded necrosis of cultivated keratinocytes as a cause of decreased proliferation. Our results suggest that DHA may potentially be used as a routine adjuvant therapy, with classical therapy of inflammatory hyperproliferative skin diseases.